miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib

BACKGROUND: Osteosarcoma (OSA), the most common primary bone malignancy, is characterized by a wide spectrum of complicated pathologies and frequent distal metastasis and causes death in adolescents and young adults worldwide. Antitumor drug treatment strategies include various cytotoxic chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Leisheng, En, He, Yang, Lei, Zhang, Yanbing, Sun, Baisheng, Gao, Jianjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709039/
https://www.ncbi.nlm.nih.gov/pubmed/31686840
http://dx.doi.org/10.2147/OTT.S215145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709039/
https://www.ncbi.nlm.nih.gov/pubmed/31686840
http://dx.doi.org/10.2147/OTT.S215145

Ejemplares similares